A Study to Evaluate the Pharmacokinetics of Abatacept Converted From Drug Substance by Two Different Processes
Status:
Completed
Trial end date:
2019-04-02
Target enrollment:
Participant gender:
Summary
The main objective of this study is to compare the pharmacokinetics (PK) of the abatacept
drug product converted from drug substance by a new drug substance process (Treatment A)
relative to the current drug substance process (Treatment B) following a single dose (750 mg)
intravenous (IV) infusion in healthy participants.